Chronic comorbidities in children and adolescents with type 1 diabetes
Publication date
2014-10-01
Authors
Fazelifarsani, Soulmaz
Souverein, Patrick C
Van Der Vorst, Marja M.J.
Knibbe, Catherijne A.J.
De Boer, Anthonius
Mantel-Teeuwisse, A.K.
Editors
Advisors
Supervisors
Document Type
Abstract
Metadata
Show full item recordCollections
License
Abstract
Background: Limited quantitative data exist on the burden of chronic comorbidities in children and adolescents with type 1 diabetes (T1D). Such knowledge is necessary for the development of guidelines and prevention programs. Objectives: To determine the incidence of chronic comorbidities in children and adolescents with T1D and to compare the risks with the diabetes-free children. Methods: A population-based cohort study was conducted using the Dutch PHARMO-RLS that comprises community pharmacy dispensing records linked to hospital admissions. Insulin prescriptions were used as a proxy to identify incident cases of T1D. All patients (
Keywords
insulin, timonacic arginine, human, insulin dependent diabetes mellitus, pharmacoepidemiology, adolescent, risk management, child, diabetes mellitus, risk, prescription, hospital admission, diagnosis, patient, cohort analysis, ICD-9, enteritis, female, colitis, mental disease, thyroid disease, girl, population, confidence interval, hazard ratio, proportional hazards model, pharmacy, migraine, cardiovascular disease, epilepsy, lung disease, diseases, anemia, monitoring, prevention, SDG 3 - Good Health and Well-being
Citation
Fazelifarsani, S, Souverein, P C, Van Der Vorst, M M J, Knibbe, C A J, De Boer, A & Mantel-Teeuwisse, A K 2014, 'Chronic comorbidities in children and adolescents with type 1 diabetes', Pharmacoepidemiology and Drug Safety, vol. 23, no. S1, 351, pp. 185. https://doi.org/10.1002/pds.3701